696 related articles for article (PubMed ID: 29512604)
1.
Agarwal P; Anvikar AR; Pillai CR; Srivastava K
Indian J Med Res; 2017 Nov; 146(5):622-628. PubMed ID: 29512604
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
[TBL] [Abstract][Full Text] [Related]
3. Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.
Chaorattanakawee S; Saunders DL; Sea D; Chanarat N; Yingyuen K; Sundrakes S; Saingam P; Buathong N; Sriwichai S; Chann S; Se Y; Yom Y; Heng TK; Kong N; Kuntawunginn W; Tangthongchaiwiriya K; Jacob C; Takala-Harrison S; Plowe C; Lin JT; Chuor CM; Prom S; Tyner SD; Gosi P; Teja-Isavadharm P; Lon C; Lanteri CA
Antimicrob Agents Chemother; 2015 Aug; 59(8):4631-43. PubMed ID: 26014942
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers.
Lim P; Dek D; Try V; Eastman RT; Chy S; Sreng S; Suon S; Mao S; Sopha C; Sam B; Ashley EA; Miotto O; Dondorp AM; White NJ; Su XZ; Char MC; Anderson JM; Amaratunga C; Menard D; Fairhurst RM
Antimicrob Agents Chemother; 2013 Nov; 57(11):5277-83. PubMed ID: 23939897
[TBL] [Abstract][Full Text] [Related]
5. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
[TBL] [Abstract][Full Text] [Related]
6. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Bustos MD; Wongsrichanalai C; Delacollette C; Burkholder B
Southeast Asian J Trop Med Public Health; 2013; 44 Suppl 1():201-30; discussion 306-7. PubMed ID: 24159833
[TBL] [Abstract][Full Text] [Related]
7. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
Sante; 2008; 18(1):43-7. PubMed ID: 18684691
[TBL] [Abstract][Full Text] [Related]
8. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
[TBL] [Abstract][Full Text] [Related]
9. Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs.
Wakoli DM; Ondigo BN; Ochora DO; Amwoma JG; Okore W; Mwakio EW; Chemwor G; Juma J; Okoth R; Okudo C; Yeda R; Opot BH; Cheruiyot AC; Juma D; Roth A; Ogutu BR; Boudreaux D; Andagalu B; Akala HM
BMC Med; 2022 Nov; 20(1):448. PubMed ID: 36397090
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of chloroquine, quinine, mefloquine and halofantrine against Gabonese isolates of Plasmodium falciparum.
Ndong JM; Atteke C; Aubouy A; Bakary M; Lébibi J; Deloron P
Trop Med Int Health; 2003 Jan; 8(1):25-9. PubMed ID: 12535246
[TBL] [Abstract][Full Text] [Related]
11. Antibiotics for prophylaxis of Plasmodium falciparum infections: in vitro activity of doxycycline against Senegalese isolates.
Pradines B; Spiegel A; Rogier C; Tall A; Mosnier J; Fusai T; Trape JF; Parzy D
Am J Trop Med Hyg; 2000 Jan; 62(1):82-5. PubMed ID: 10761729
[TBL] [Abstract][Full Text] [Related]
12. Changing Antimalarial Drug Sensitivities in Uganda.
Rasmussen SA; Ceja FG; Conrad MD; Tumwebaze PK; Byaruhanga O; Katairo T; Nsobya SL; Rosenthal PJ; Cooper RA
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923866
[TBL] [Abstract][Full Text] [Related]
13. Piperaquine resistant Cambodian Plasmodium falciparum clinical isolates: in vitro genotypic and phenotypic characterization.
Boonyalai N; Vesely BA; Thamnurak C; Praditpol C; Fagnark W; Kirativanich K; Saingam P; Chaisatit C; Lertsethtakarn P; Gosi P; Kuntawunginn W; Vanachayangkul P; Spring MD; Fukuda MM; Lon C; Smith PL; Waters NC; Saunders DL; Wojnarski M
Malar J; 2020 Jul; 19(1):269. PubMed ID: 32711538
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo responses of Plasmodium falciparum clinical isolates to conventional and new antimalarial drugs in Niger.
Issaka M; Salissou A; Arzika I; Guillebaud J; Maazou A; Specht S; Zamanka H; Fandeur T
Antimicrob Agents Chemother; 2013 Jul; 57(7):3415-9. PubMed ID: 23612203
[TBL] [Abstract][Full Text] [Related]
15. A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs.
Quashie NB; Duah NO; Abuaku B; Quaye L; Ayanful-Torgby R; Akwoviah GA; Kweku M; Johnson JD; Lucchi NW; Udhayakumar V; Duplessis C; Kronmann KC; Koram KA
Malar J; 2013 Dec; 12():450. PubMed ID: 24341604
[TBL] [Abstract][Full Text] [Related]
16. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs.
Fall B; Diawara S; Sow K; Baret E; Diatta B; Fall KB; Mbaye PS; Fall F; Diémé Y; Rogier C; Wade B; Bercion R; Pradines B
Malar J; 2011 Oct; 10():310. PubMed ID: 22014157
[TBL] [Abstract][Full Text] [Related]
18. The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs.
Quashie NB; Duah NO; Abuaku B; Koram KA
Ann Trop Med Parasitol; 2007 Jul; 101(5):391-8. PubMed ID: 17550644
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change.
Tinto H; Bonkian LN; Nana LA; Yerbanga I; Lingani M; Kazienga A; Valéa I; Sorgho H; Kpoda H; Guiguemdé TR; Ouédraogo JB; Mens PF; Schallig H; D'Alessandro U
Malar J; 2014 May; 13():207. PubMed ID: 24885950
[TBL] [Abstract][Full Text] [Related]
20. Correlation between in vitro and in vivo antimalarial activity of compounds using CQ-sensitive and CQ-resistant strains of Plasmodium falciparum and CQ-resistant strain of P. yoelii.
Srivastava K; Agarwal P; Soni A; Puri SK
Parasitol Res; 2017 Jul; 116(7):1849-1854. PubMed ID: 28502016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
